Marija Sarić Matutinović, M.Pharm.

Marija Sarić Matutinović was born on March 8, 1987 in Belgrade where she graduated from elementary school and the Third Belgrade Gymnasium. She graduated in 2012 at the University of Belgrade - Faculty of Pharmacy with an average grade of 9.18. She defended her master thesis entitled "Parameters of oxidative stress and antioxidative status in children with acute pyelonephritis as indicators of kidney function and duration of infection" at the Department of Medical Biochemistry. After graduation, she completed a mandatory internship at the Center for Medical Biochemistry, University Clinical Center of Serbia. She passed the state exam for masters of pharmacy - medical biochemists in 2013 before the examination commission of the Ministry Department of Health, Republic of Serbia.

She started her PhD studies at the University of Belgrade - Faculty of Pharmacy, module Medical Biochemistry, in 2014/2015. Since March 2015, she has been engaged on the project of the Ministry of Education, Science and Technological Development of the Republic of Serbia ON175036 entitled "Biomarkers of organ damage and dysfunction" led by Prof. Dr. Svetlana Ignjatović. From 2015/2016 Marija Sarić Matutinović was engaged in conducting practical classes at the Integrated Academic Studies, at the Department of Medical Biochemistry. In 2021 she was elected a teaching assistant for the scientific field of Medical Biochemistry at the University of Belgrade - Faculty of Pharmacy. The same year, she was elected a research assistant at the University of Belgrade - Faculty of Pharmacy. She was a mentor of student scientific research and a member of the Commission for master’s thesis. She authored and reviewed a number of publications published in prominent international and domestic journals. She is a member of the Society of Medical Biochemists of Serbia, the Chamber of Biochemists of Serbia, and EFLM Academy (European Federation for Laboratory Medicine Academy).

• Sarić Matutinović M, Diana T, Nedeljković Beleslin B, Ćirić J, Žarković M, Kahaly GJ, Ignjatović S. Clinical value of functional thyrotropin receptor antibodies in Serbian patients with Graves' orbitopathy. J Endocrinol Invest. 2021 (IF 4,256; 63/145 Endocrinology & Metabolism)
• Bećarević M, Sarić Matutinović M, Žarkovic M, Nedeljković Beleslin B, Ćirić J, Ignjatović S. Antiphospholipid antibodies in patients with Graves' orbitopathy: preliminary data. Endocrine 2021. (IF 3,633; 83/145 Endocrinology & Metabolism)
• Vidojevic D, Seman S, Lasica R, Tesic M, Sarić Matutinovic M, Jovicic S, Ignjatovic S, Arena R, Damjanovic S, Popovic D. Alpha-melanocyte-stimulating hormone during exercise recovery has prognostic value for coronary artery disease. Horm-Int J Endocrino 2021;20(2):381-387. (IF 2,885; 106/145 Endocrinology & Metabolism)
• Dinčić M, Čolović BM, Sarić Matutinović M, Ćetković M, Stevović KT, Mougharbel SA, Todorović J, Ignjatović S, Radosavljević B, Milisavljević M, Kortz U, Krstić ZD. In vivo toxicity evaluation of two polyoxotungstates with potential antidiabetic activity using Wistar rats as a model system. RSC Adv 2020;10:2846-2855. (IF 3,390; 82/178 Chemistry, Multidisciplinary)
• Milinković N, Sarić M, Jovičić S, Mirković D, Ležaić V, Ignjatović S. Lipid status association with 25-hydroxy vitamin D: cross sectional study of end stage renal disease patients. J Med Biochem 2020;39:309-317. (IF 3,402; 181/297 Biochemistry & Molecular Biology)
• Milinković N, Sarić Matutinović M, Pejanović S, Ignjatović S. Comparison between bone alkaline phosphatase immunoassay and electrophoresis technique in hemodialysis patients. J Med Biochem 2020;39:178-183. (IF 3,402; 181/297 Biochemistry & Molecular Biology)
• Bećarević M, Sarić M, Stojanović Lj, Mirković D, Dopsaj V, Ignjatović S. Anti-annexin A5 antibodies and 25-hydroxy-cholecalciferol in female patients with primary antiphospholipid syndrome. Clin Rheumatol 2018;37:3359-3364. (IF 2,980; 24/34 Rheumatology)